1. HBW Insight
  2. >>Geography
  3. >>North America

Shareholders Challenge Perrigo's Defense Against Mylan Offer Two Years Earlier

 
• By Eileen Francis

Perrigo concealed problems related to its 2015 acquisition of Omega and over-inflated the firm’s resistance to generic drug pricing pressures in its defense against Mylan's tender, shareholder group Carmignac Gestion says in a lawsuit.

Economics graph

Perrigo Co. PLC'sreasons for rejecting Mylan NV's hostile takeover in 2015 have been recast as reasons for a lawsuit alleging the OTC private label giant overstated its strengths and downplayed its weaknesses to sway shareholders against the offer.

Perrigo's management concealed problems with Omega Pharma NV, which it acquired to bolster its position as an international business also marketing branded consumer health products, and understated the impact...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America